openPR Logo
Press release

Autologous Fat Grafting Market Expected to Secure Notable Revenue Share during 2018-2026(Based on application type, the autologous fat grafting market is segmented as: Breast Augmentation Parts of the Face Buttocks Augmentation Other Parts of the Body)

05-21-2019 09:14 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Autologous Fat Grafting Market Expected to Secure Notable

Autologous Fat Grafting Market: Introduction

Autologous fat grafting is a minimally invasive method used for the removal of unwanted fat from one area of the body and re-injecting it into a desired area. Patients prefer this method of fat grafting because it is a natural and safe method.

New products have been developed with new technologies for the autologous fat grafting market. The fat tissues are extracted and harvested. Once the fat is harvested, it is cleaned and isolated through centrifuging. The centrifuge separates the undamaged cells from the damaged ones, and these are transplanted into the desired location.

The average time required for a fat grafting procedure is 30-40 minutes. Increase in the demand of aesthetic treatments from younger patients is expected to boost the autologous fat grafting market. Fat transfer is expected to be the future of aesthetic treatments. Autologous fat grafting is performed to restore a youthful facial appearance, enhance the lips or to fill in lines & creases that develop with age. Moreover, autologous fat grafting lasts longer in the non-movement areas such as under the eyes and sunken cheeks.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2701

Factors Driving the Autologous Fat Grafting Market

The procedure of transferring fat is not new, however, fat grafting has been developed in the recent past. Over 900,000 fat graft procedures were performed in 2015, according to the International Society of Aesthetic Plastic Surgery (ISAPS). Fat grafting also reduces allergic reactions and tissue rejections. Moreover, the influence of media and the film & fashion industries is also boosting the autologous fat grafting market. In addition, the rising prevalence of diseases, such as obesity and accidents, is boosting the number of treatments, which is also boosting the market. These procedures are also providing opportunities for a combination of treatments, which is also expected to increase the number of autologous fat grafting procedures.

Increase in the demand for natural and effective treatments by customers is also expected to boost the autologous fat grafting market. These procedures have the ability to treat the fine lines & wrinkles, due to which a larger number of people are likely to invest in them. The ability to perform breast augmentation through autologous fat grafting is also driving the market as it can be performed on women who are either unsuitable for implants or not wanting implants. Moreover, autologous fat transfer does not leave any scar on or under the breasts. However, the transfer of a large volume of fat is not advisable as the chances of the survival of the patient are lesser as compared to small transfer volumes.

Autologous Fat Grafting Market: Regional Outlook

Geographically, the global autologous fat grafting market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East & Africa, and Japan. North America is expected to be a dominant regional market for autologous fat grafting, followed by Europe, due an increase in the number of procedures in the U.S. as well as technological advancements in these procedures. Asia Pacific is expected to grow at a higher rate with growth in the number of awareness programs and the influence of the media. Japan is projected to be one of the leading countries in the autologous fat grafting market in the upcoming years. The Latin America autologous fat grafting market is also expected to witness significant growth during the forecast period.

Examples of some of the major players identified across the value chain of the autologous fat grafting market are Genesis Biosystems, Inc.; Galderma S.A.; Allergan; Integra LifeSciences Corporation; Sanofi; SciVision Biotech Inc.; Valeant and Ranfac Corp. These players in the autologous fat grafting market are forming collaborations to exploit the potential growth opportunities in the market. In addition, they are mainly focused on strengthening the core competencies of their product portfolio.

Autologous Fat Grafting Market: Segmentation

The autologous fat grafting market has been segmented on the basis of application, end users and geography.

Based on application type, the autologous fat grafting market is segmented as:

Breast Augmentation
Parts of the Face
Buttocks Augmentation
Other Parts of the Body
Based on end user, the autologous fat grafting market is segmented as:

Hospitals
Clinics
Short-stay Facility
Based on region, the autologous fat grafting market is segmented as:

North America
Latin America
Europe
Asia Pacific Excluding Japan
Japan
Middle East & Africa
Key data points covered in report

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2701

The report covers exhaustive analysis on:

Autologous Fat Grafting Market by age group, end user and region
Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by application, end user and country segments
Autologous Fat Grafting Market Dynamics & Opportunity Assessment
Historical Actual Market Size, 2013 - 2017
Autologous Fat Grafting Market system market Size & Forecast 2018-2028
Autologous Fat Grafting Market Current Trends/Issues/Challenges
Competition & Companies involved
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size, and recent industry trends
Key Competition landscape, market structure, regulatory scenario
Epidemiology outlook for diseases
Economical spending, regional healthcare outlook, consumer healthcare expenditure
Availability of device, cost of the test, specificity and sensitivity
Strategies for key players and product offerings, channel strategies, regional foot print, channel footprint
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance in terms of value and volume

Report Analysis@ https://www.factmr.com/report/2701/autologous-fat-grafting-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autologous Fat Grafting Market Expected to Secure Notable Revenue Share during 2018-2026(Based on application type, the autologous fat grafting market is segmented as: Breast Augmentation Parts of the Face Buttocks Augmentation Other Parts of the Body) here

News-ID: 1746732 • Views:

More Releases from Fact.MR

CAR T-Cell Therapy Market will Reach USD 11.49 Billion by 2034 | Autolus Therapeutics; 2Seventy Bio, Inc.; Bristol-Myers Squibb; Pfizer; Gilead Sciences
09-25-2025 | Health & Medicine
Fact.MR
CAR T-Cell Therapy Market will Reach USD 11.49 Billion by 2034 | Autolus Therape …
The global CAR T-cell therapy market is poised for significant expansion, valued at USD 2.25 billion in 2024 and projected to reach USD 11.49 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 17.7% over the forecast period. This growth is driven by the increasing incidence of cancer, strong product pipelines, and advancements in immunotherapy. According to the World Health Organization, cancer affects one in five individuals
Invisible Orthodontics Market Poised for Significant Growth, lead by Angel Aligner; SmarTee; Dentsply Sirona; Institut Straumann AG; SCHEU DENTAL GmbH; Ormco Corporation
09-25-2025 | Health & Medicine
Fact.MR
Invisible Orthodontics Market Poised for Significant Growth, lead by Angel Align …
The global invisible orthodontics market is experiencing a transformative surge, driven by advancements in dental technology and a growing demand for aesthetic dental solutions. Valued at US$4.0 billion in 2024, the market is projected to expand at a Compound Annual Growth Rate (CAGR) of 5.2%, reaching US$6.65 billion by 2034, according to recent industry analyses. Market Dynamics and Growth Drivers: The increasing preference for discreet orthodontic treatments is a primary factor contributing
Neuropathic Pain Market is Projected to Reach USD 14,538.7 Million by 2034 | Pfizer Inc.; Johnson & Johnson Services, Inc; Bristol-Myers Squibb Company; Sanofi S.A; GlaxoSmithKline plc
09-25-2025 | Health & Medicine
Fact.MR
Neuropathic Pain Market is Projected to Reach USD 14,538.7 Million by 2034 | Pfi …
The global neuropathic pain market is poised for significant growth, valued at USD 6,316.6 million in 2024 and projected to reach USD 14,538.7 million by 2034, reflecting a compound annual growth rate (CAGR) of 5.7% over the forecast period. This expansion is driven by the rising prevalence of chronic conditions such as diabetes and cancer, an aging global population, and advancements in personalized medicine and pain management therapies. With neuropathic
Crop Growth Regulator Market to Reach US$ 7.07 Billion by 2034, Driven by Sustainable Farming Solutions
09-25-2025 | Food & Beverage
Fact.MR
Crop Growth Regulator Market to Reach US$ 7.07 Billion by 2034, Driven by Sustai …
The global crop growth regulator market is entering a phase of sustained expansion, driven by increasing demand for efficient agricultural solutions, enhanced crop yields, and sustainable farming practices. Worldwide revenue from sales of crop growth regulators is estimated to stand at US$ 3.68 billion in 2024 and is projected to grow at a robust CAGR of 6.7%, reaching US$ 7.07 billion by 2034, according to the latest insights from Fact.MR. Drivers

All 5 Releases


More Releases for Autologous

Transformative Trends Impacting the Autologous Cell Therapy Market Landscape: Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Autologous Cell Therapy Market Size By 2025? The market size for autologous cell therapy has seen a swift expansion in the past few years. The growth is projected to increase from $10.28 billion in 2024 to $12.19 billion in 2025, at a compound annual growth
Emerging Trends Influencing The Growth Of The Autologous Cell Therapy Market:Tec …
The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Autologous Cell Therapy Market Size Expected to Be by 2034? The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from
Prominent Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trend fo …
What Are the Projected Growth and Market Size Trends for the Autologous Stem Cell And Non-Stem Cell Based Therapies Market? The market size for autologous stem cell and non-stem cell based treatments has experienced rapid expansion in recent years. In numerical terms, it is predicted to rise from $9.96 billion in 2024 to $11.59 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. The significant growth during the
Autologous Cell Therapy Market Growth Outlook 2027
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027. Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715 Overview • Cell therapy also termed as cellular therapy
Autologous Cell Therapy Market Insights Shared in Detailed Report
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027. Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715 Overview • Cell therapy also termed as cellular therapy
Autologous Cell Therapy Market: High Prevalence of Cancer Triggers Demand for Au …
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell